REDEEMABLE CONVERTIBLE PREFERRED STOCK ESCROWED PROCEEDS AND STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended					3 Months Ended	6 Months Ended	12 Months Ended
	May 11, 2022	Jun. 20, 2024	Feb. 29, 2024	Oct. 20, 2023	Dec. 16, 2022	Oct. 31, 2022	Dec. 31, 2022	Dec. 31, 2022	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022	Jan. 31, 2024	Jun. 30, 2021
Stock based compensation, options							$ 121,584	$ 382,541	$ 873,633	$ 794,735
Unrecognized compensation cost									$ 1,409,506
Weighted-average period									2 months 21 days
Number of common stock share						798,182			1,033,491	1,033,491
Exercise price per share				$ 2.12		$ 5.83						$ 5.46
Fees and expenses				$ 4,573,948		$ 9,109,117			$ 9,224,056
Gross proceeds									$ 10,000,006,000,000
Voting of shares description									The holders of Series C Preferred Stock were entitled to 20,000 votes per share
Exercise price				$ 0.0001		$ 0.0001			$ 6.82
Description of commission									The Company pays Canaccord 3.0% of the gross proceeds as a commission
Unvested performance-based restricted stock									$ 264,945	$ 238,838	$ 60,566		$ 95,167
Unvested performance-based stock options granted to executive officers and other employees									418,945
Unvested performance-based stock options granted									88,911
Stock based compensation, restricted stock units									$ 839,335	616,182
Outstanding vested restricted stock unit									508,011
Description of securities purchase agreement			the Company issued to the investors in the January 2024 RD Offering unregistered warrants (the “January 2024 Private Warrants”) to purchase up to 1,831,503 shares of the Company’s common stock (the “January 2024 Private Warrant Shares”) in a concurrent private placement (the “January 2024 Private Offering” and together with the January 2024 RD Offering, the “January 2024 Offering”). The shares of common stock and accompanying January 2024 Private Warrants were offered at a combined offering price of $5.46			(i) 1,020,000 shares of the Company’s common stock, (ii) prefunded warrants (the “October 2022 Pre-Funded Warrants”) to purchase up to 798,182 shares of the Company’s common stock, and (iii) common stock warrants (the “October 2022 Common Warrants”) to purchase up to 1,818,182 shares of the Company’s common stock. Each share of common stock was offered with one accompanying October 2022 Common Warrant with a combined offering price of $5.50. Each October 2022 Pre-Funded Warrant was offered with one accompanying October 2022 Common Warrant with a combined offering price of $5.4999
Total gross proceeds									$ 15,000,000
Account to release									171,000,000
Distributable value of dividend									100
Selling, general and administrative expenses									12,270,046	15,290,836
Gross proceeds from exercise of Existing Warrants									$ 6,045,642	$ 78
Stock Warrants [Member]
Warrants to purchase		3,233,277
Stock Warrant Description		Company’s agreement to (i) lower the exercise price to $1.88 per share for the 3,233,277 Existing Warrants being exercised pursuant to the Inducement Letter and (ii) issue to the Exercising Holder an aggregate of 4,849,915 warrants to purchase shares of common stock, comprised of Series A common stock purchase warrants to purchase 2,727,273 shares of common stock (the “Series A Warrants”) and Series B common stock purchase warrants to purchase 2,122,642 (of which 1,624,201 shares of common stock are subject to stockholder approval) shares of common stock
Gross proceeds from exercise of Existing Warrants		$ 6,078,561
Executive Officers [Member]
Unvested performance-based stock options granted to executive officers and other employees									274,549
Unvested performance-based stock options granted									59,842
Unvested performance-based restricted stock units granted									184,443	152,432	40,707		22,343
Convertible Series A Preferred Stocks [Member]
Convertible preferred stock were outstanding									4,030
Aggregate value									$ 403,000
Conversion price									$ 75.45
Convertible shares									$ 1.33
Distributable value of dividend									$ 100
Distributable value of dividend additional									100
Series B Convertible Preferred Stock [Member]
Fee									750,000
Selling, general and administrative expenses											$ 150,995
Fair value of the warrants											$ (234,443)
Securities Purchase Agreement Plan [Member] | Series B and C Redeemable Convertible Preferred Stock [Member]
Exercise price	$ 12.50
Account to release									15,750,000
Fee									750,000
Warrants to purchase up	66,666
Total gross proceeds from the offering									$ 15,000,000
Expiry of share issuance	48 months
Securities Purchase Agreement [Member] | Series B Redeemable Convertible Preferred Stock [Member]
Shares sold	8,100,000
Securities Purchase Agreement [Member] | Series C Redeemable Convertible Preferred Stock [Member]
Shares sold	900,000
Share purchase price	$ 1.67
2011 Stock Incentive Plan [Member] | President and CEO [Member]
Voluntarily contributed stock options number of share					143,360
2011 Stock Incentive Plan [Member] | CFO and COO [Member]
Voluntarily contributed stock options number of share					124,220
2011 Stock Incentive Plan [Member] | Non-employee Directors And Consultants [Member]
Voluntarily contributed stock options number of share									4,300,000
Shares available for grant									206,474
2023 Equity Distribution Agreement [Member]
Description of equity distribution agreement									The 2023 Equity Distribution Agreement and related prospectus is limited to sales of up to an aggregate maximum $50.0 million of shares of the Company’s common stock
Vesting of restricted share units									25,467	20,468
Vesting of restricted share units value aggregate									$ 56,401	$ 146,062